Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Shih HT, Webb CR, Conway WA, Peterson E, Tilley B, Goldstein S. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 1988; 94: 44–48.
Antonelli Incalzi R, Pistelli R, Fuso L, Cocchi A, Bonetti MG, Giordano A. Cardiac arrhythmias and left ventricular function in respiratory failure from chronic obstructive pulmonary disease. Chest 1990; 5: 1092–1097.
Tirlapur VG, Mir MA. Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airway disease. N Engl J Med 1982; 306: 125–130.
Levine PA, Klein MD. Mechanisms of arrhythmias in chronic obstructive lung disease. Geriatrics 1976; 31: 47–56.
Biggs FD, Lefrak SS, Kleiger RE, Senior RM, Oliver GC. Disturbances of rhythm in chronic lung disease. Heart Lung 1977; 6: 256–261.
Green LH, Smith TW. The use of digitalis in patients with pulmonary disease. Ann Intern Med 1977; 87: 459–465.
Bittar G, Friedman HS. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991; 99: 1415–1420.
Conradson TB, Eklundh G, Olofsson B, Pahlm O, Persson G. Cardiac arrhythmias in patients with mild to moderate obstructive lung disease. Comparison of beta-agonist therapy alone and in combination with a xanthine derivative, enprophylline or theophylline. Chest 1985; 88: 537–542.
Josephson GW, Kennedy HL, Mackenzie EJ, Gibson G. Cardiac dysrhythmias during the treatment of acute asthma. Chest 1980; 78: 429–435.
Pierson DJ, Hudson LD, Stark K, Hedgecock M. Cardiopulmonary effects of terbutaline and a bronchodilatator combination in chronic obstructive pulmonary disease. Chest 1980; 77: 176–182.
Davies SW, John LM, Wedzicha JA, Lipkin DP. Overnight studies in severe chronic left heart failure: arrhythmias and oxygen desaturation. Br Heart J 1991; 65: 77–83.
Coccagna G, Lugaresi E. Arterial blood gases and pulmonary and systemic pressure during sleep in chronic obstructive pulmonary disease. Sleep 1978; 1: 117–124.
Boysen PG, Block AJ, Wynne JW, Hunt LA, Flick MR. Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease. Chest 1979; 76: 536–542.
Douglas NJ, Calverley PMA, Leggett RJE, Brash HM, Fenley DC, Brezinova V. Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet 1979; i: 1–4.
Day CP, McComb JM, Campbell RWF. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342–344.
Han J, Moe GK. Nonuniform recovery of excitability in ventricular muscle. Circ Res 1964; 14: 44–60.
Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995; 25: 746–752.
Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920; 7: 353–370.
Pye M, Ferrel TG, Cobbe SM. QT interval dispersion in patients with sustained ventricular tachycardia or fibrillation (abstract). Eur Heart J 1992; 13(Suppl.): 221.
Bonatti V, Rolti A, Bolti G. Recording of monophasic action potentials of right ventricle in long QT syndromes complicated by ventricular arrhythmias. Eur Heart J 1983; 4: 168–174.
Merx W, Yoon MS, Han J. The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Am Heart J 1977; 94: 603–612.
Reynolds RJ, Buford JG, George RB. Treating asthma and COPD in patients with heart disease. J Respir Dis 1982; 3: 41–51.
Scarduelli C, Sella D, Rosa A, Belfanti D, Buzzi G, Guerra G, Sturani C. Aritmie cardiache nella insufficienza respiratoria cronica da broncopneumopatia cronica ostruttiva: incidenza e correlazione con le turbe respiratorie notturne. Cardiologia 1991; 5: 379–384.
Linker NJ, Colonna P, Kekwick CA, Till J, Camm J, Ward DE. Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 1992; 69: 634–638.
Priori SG, Napolitano C, Diehl L, Schwartz PJ. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994; 89: 1681–1689.
Day CP, McComb JM, Campbell RWF. Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J 1991; 12: 423–427.
Zareba W, Moss AJ, le Cassie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol 1994; 74: 550–553.
Glancy JM, Garratt CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet 1995; 345: 945–948.
Higham PD, Furniss SS, Campbell RWF. QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J 1995; 73: 32–36.
Silverman HS, Stern MD. Ionic basis of ischaemic cardiac injury: insights from cellular studies. Cardiovasc Res 1994; 28: 581–597.
Janse MJ, Wit AS. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989; 69: 1049–1169.
Vankatesh N, Lamp ST, Weiss JM. Sulfonylureas, ATP sensitive potassium channels and cellular K loss during hypoxia, ischemia and metabolic inhibition in mammalian ventricle. Circ Res 1991; 69: 623–637.
Billman GE. Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischemia. Cardiovasc Res 1994; 28: 251–258.
Coronel R. Heterogeneity in extracellular potassium concentration during early myocardial ischaemia and reperfusion: implication for arrhythmogenesis. Cardiovasc Res 1994; 28: 770–777.